Epigenetics of dysfunctional oral epithelium in people living with HIV and risk for HPV infection

HIV 感染者口腔上皮功能障碍的表观遗传学和 HPV 感染风险

• 批准号: 10709070
• 负责人: Martin Sapp
• 金额: $ 25.09万
• 依托单位: CASE WESTERN RESERVE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-07-03 至 2025-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10709070
• 关键词: ATAC-seq; Address; Age; Benign; Bioinformatics; Biological Assay; Biopsy; COVID-19; Cancer Detection; Cardiovascular Diseases; Cell Separation; Cells; Cellular Stress; Cellular biology; Chromatin; Chronic; Clinical; Clustered Regularly Interspaced Short Palindromic Repeats; Collecting Cell; Contracts; DNA; DNA Modification Methylases; Data; Data Set; Disease; Epigenetic Process; Epithelial Cells; Epithelium; Event; Exhibits; Functional disorder; Future; Gene Expression; General Population; Genes; Genetic; Genomics; Goals; HIV; HIV Infections; HIV Seronegativity; HIV/AIDS; Head and Neck Cancer; Health; Health Care Costs; Histone Deacetylase; Human; Human Papillomavirus; Human papilloma virus infection; Human papillomavirus 16; Immune; In Vitro; Incidence; Individual; Infection; Innate Immune Response; Intervention; Life Cycle Stages; Life Expectancy; Liver diseases; Malignant Neoplasms; Malignant neoplasm of liver; Mediating; Methods; Modeling; Molecular; Mouth Carcinoma; Mouth Diseases; Netherlands; Oral; Oral Pathology; Oral cavity; Oral health; Oral mucous membrane structure; Oropharyngeal; Osteoporosis; Pathway interactions; Patients; Periodontal Diseases; Persons; Predisposition; Proteome; Proteomics; Quality of life; Race; Reproducibility; Research; Risk; Risk Reduction; Sampling; Secondary to; System; Techniques; Testing; Therapeutic Studies; Tissues; Treatment-related toxicity; Viral; Virus Diseases; age related; antiretroviral therapy; cell age; differential expression; epigenetic marker; epigenome; epigenomics; genome-wide; guided inquiry; high risk; improved; in vivo; keratinocyte; lonely individuals; malignant mouth neoplasm; microbial; mouth squamous cell carcinoma; neurocognitive disorder; novel; oral HIV; oral cavity epithelium; oral infection; oral wart; permissiveness; sex; small hairpin RNA; small molecule; stem; transcriptome; transcriptome sequencing; transcriptomic profiling; transcriptomics; virology; ATAC-seq; Address; Age; Benign; Bioinformatics; Biological Assay; Biopsy; COVID-19; Cancer Detection; Cardiovascular Diseases; Cell Separation; Cells; Cellular Stress; Cellular biology; Chromatin; Chronic; Clinical; Clustered Regularly Interspaced Short Palindromic Repeats; Collecting Cell; Contracts; DNA; DNA Modification Methylases; Data; Data Set; Disease; Epigenetic Process; Epithelial Cells; Epithelium; Event; Exhibits; Functional disorder; Future; Gene Expression; General Population; Genes; Genetic; Genomics; Goals; HIV; HIV Infections; HIV Seronegativity; HIV/AIDS; Head and Neck Cancer; Health; Health Care Costs; Histone Deacetylase; Human; Human Papillomavirus; Human papilloma virus infection; Human papillomavirus 16; Immune; In Vitro; Incidence; Individual; Infection; Innate Immune Response; Intervention; Life Cycle Stages; Life Expectancy; Liver diseases; Malignant Neoplasms; Malignant neoplasm of liver; Mediating; Methods; Modeling; Molecular; Mouth Carcinoma; Mouth Diseases; Netherlands; Oral; Oral Pathology; Oral cavity; Oral health; Oral mucous membrane structure; Oropharyngeal; Osteoporosis; Pathway interactions; Patients; Periodontal Diseases; Persons; Predisposition; Proteome; Proteomics; Quality of life; Race; Reproducibility; Research; Risk; Risk Reduction; Sampling; Secondary to; System; Techniques; Testing; Therapeutic Studies; Tissues; Treatment-related toxicity; Viral; Virus Diseases; age related; antiretroviral therapy; cell age; differential expression; epigenetic marker; epigenome; epigenomics; genome-wide; guided inquiry; high risk; improved; in vivo; keratinocyte; lonely individuals; malignant mouth neoplasm; microbial; mouth squamous cell carcinoma; neurocognitive disorder; novel; oral HIV; oral cavity epithelium; oral infection; oral wart; permissiveness; sex; small hairpin RNA; small molecule; stem; transcriptome; transcriptome sequencing; transcriptomic profiling; transcriptomics; virology

With the increase in life expectancy of people living with HIV (PLWH), principally due to the introduction of antiretroviral therapy (ART), it has become evident that these individuals differentially acquire a wide range of health problems, including oral health complications, which severely impact quality of life and incur substantial healthcare costs. We previously identified an altered proteomic profile of human oral keratinocytes isolated from PLWH patients, suggesting elevated cellular stress and reduced ability to provide robust innate immune protection. We also demonstrated that these epithelial cells display altered epigenetic markers, reduced proliferative capacity and respond weakly to microbial challenges. We now hypothesize that in PLWH, oral epithelial cell dysfunction predisposes towards susceptibility to secondary viral infections, such as HPV. We have assembled an interdisciplinary team of experts whose expertise encompasses HIV and HPV virology, oral and epithelial cell biology, epigenomics and bioinformatics. We propose to apply a novel non-invasive method of collecting oral mucosal cells from PLWH and conduct genomic and epigenomic analyses of the oral epithelium (Aim 1). Additionally, using a relevant HPV infection model, we wish to determine if such cells expanded from the oral mucosa of PLWH, which we have demonstrated exhibit an altered proteome, are more susceptible to HPV infection when compared to oral epithelial cells from healthy controls (Aim 2). These studies will be the first to establish the transcriptomic and epigenomic effects of HIV infection on primary epithelial cells, establish a new culture-based assay system so critical for future mechanistic and therapeutic studies, and enable direct comparisons between these in vivo and in vitro methods to robustly identify key molecular features that are central to the increased HPV susceptibility seen in PLWH. Successful completion of the goals of this R21 will enable targeted hypothesis-based genomic or epigenomic studies (i.e. shRNAs, CRISPR, or small molecules) to identify specific genes/pathways mediating the HPV susceptibility, and functionally test HPV infection levels. Validating the epigenetic basis of susceptibility to HPV infection in PLWH will eventually guide the discovery and application of novel epigenomic-based clinical interventions; all consistent with the goals of the NOSI NOT-DE-21-019 “Basic and translational oral health research related to HIV/AIDS.”

随着艾滋病毒（PLWH）的人们的预期寿命增加，主要是由于引入 抗逆转录病毒疗法（ART）已成为证据，表明这些人对广泛的范围有所不同 健康问题，包括口腔健康并发症，严重影响生活质量和产生 大量的医疗费用。我们先前确定了人口服的蛋白质组学变化 从PLWH患者中分离出的角质形成细胞，表明细胞应激升高，并降低了能力 提供强大的先天免疫保护。我们还证明了这些上皮细胞显示的变化 表观遗传标记，降低增殖能力并对微生物挑战的反应较弱。 现在，我们假设在PLWH中，口服上皮细胞功能障碍倾向于 对继发病毒感染的敏感性，例如HPV。我们组装了一个跨学科 专家团队的专业知识包括艾滋病毒和HPV病毒学，口腔和上皮细胞生物学， 表观基因组学和生物信息学。我们建议采用一种新颖的非侵入性方法来收集口服 来自PLWH的粘膜细胞并进行口腔上皮的基因组和表观基因组分析（AIM 1）。 此外，使用相关的HPV感染模型，我们希望确定此类细胞是否从 我们已经证明了蛋白质组改变的PLWH的口服粘膜，更容易受到 与健康对照中的口腔上皮细胞相比，HPV感染（AIM 2）。这些研究将是 第一个建立HIV感染对原发性上皮细胞的转录组和表观基因组作用的是 建立一个新的基于文化的评估系统，对于未来的机械和治疗研究至关重要， 启用这些体内和体外方法之间的直接比较，以稳健地识别关键分子 在PLWH中看到的HPV易感性提高的核心。 成功完成此R21的目标将实现基于假设的基因组或 表观基因组研究（即shRNA，CRISPR或小分子）以识别特定的基因/途径 介导HPV敏感性，并在功能上测试HPV感染水平。验证表观基础 PLWH中HPV感染的敏感性最终将指导新颖的发现和应用 基于表观基因组的临床干预措施；所有这些都与Nosi Not-De-De-21-019的目标一致。 并翻译了与艾滋病毒/艾滋病有关的口腔健康研究。”